Novartis: all 3,900 studies
Page 37 of 39. Open to participants first (226), then studies with results posted, then the rest; newest registration first within each.
- A Clinical Study to Evaluate Safety & Efficacy of the Combination of Aliskiren, Valsartan & Hydrochlorothiazide in Diabetic Hypertensive Nonresponder PatientsCompletedNCT00219102Phase 3
- A Clinical Study to Evaluate the Safety and Efficacy of Aliskiren Alone and in Combination With Ramipril in Hypertensive, Diabetic Patients.CompletedNCT00219089Phase 3
- A Clinical Study to Evaluate the Safety and Efficacy of the Combination of Aliskiren and Amlodipine in Hypertensive Non Responders PatientsCompletedNCT00219076Phase 3
- A Clinical Study to Compare an Aliskiren Based Hypertensive Regimen With a Ramipril Based One Followed by a Randomized Withdrawal.CompletedNCT00219063Phase 3
- A Clinical Study to Compare the Safety and Efficacy of an Aliskiren-based Regimen With a Lisinopril Based Regimen in Patients With Severe HypertensionCompletedNCT00219050Phase 3
- Long Term Safety of Aliskiren Alone or With the Optional Addition of Hydrochlorothiazide in Patients With Essential HypertensionCompletedNCT00219037Phase 3
- Clinical Study to Evaluate the Efficacy and Safety of Aliskiren Alone and in Combination With Hydrochlorothiazide in Patients With Essential Hypertension.CompletedNCT00219024Phase 3
- "ALOFT - Aliskiren Observation of Heart Failure Treatment": Efficacy and Safety of Aliskiren Added on Top of Standard Therapy in Adults (≥ 18 Years) With Stable Heart FailureCompletedNCT00219011Phase 3
- Zoledronic Acid in the Treatment of Breast Cancer With Minimal Residual Disease in the Bone MarrowTerminatedNCT00172068Phase 2
- Study to Assess Efficacy and Safety of Zoledronic Acid and the Value of Markers of Bone Resorption in the Prediction of Bone Metastases and Cancer Treatment-induced Bone Loss (CTIBL) in Patients With Prostate Cancer on Hormone TherapyCompletedNCT00172055Phase 3
- Study Comparing Full-dose Radiotherapy Versus Reduced Dose in the Management of Bone Metastasis in Patients With Breast Cancer Receiving Zoledronic AcidCompletedNCT00172029Phase 4
- A Study to Evaluate the Efficacy and Tolerability of Zoledronic Acid in Patients With Metastatic Prostate Cancer Who Can be Treated With a Group of Medications Known as BisphosphonatesCompletedNCT00172016Phase 4
- Effect of Zoledronic Acid in Patients With Renal Cell Cancer and Bone MetastasisCompletedNCT00172003Phase 4
- Efficacy and Safety of Oral Famciclovir in Patients With Active Recurrent Genital HerpesCompletedNCT00171990Phase 3
- Post-Marketing Clinical Study of Postoperative Adjuvant Therapy With Imatinib Mesylate in Patients With Gastrointestinal Stromal Tumors (GIST)CompletedNCT00171977Phase 4
- Efficacy and Tolerability of Zoledronic Acid With Radiotherapy in Pts With Advanced Osteolytic Bone LesionsCompletedNCT00171964Phase 4
- Open-label Trial of Imatinib Mesylate in Patients With Unresectable Recurrent Glioblastoma Multiforme Expressing PDGFR (Platelet Derived Growth Factor Receptors)TerminatedNCT00171938Phase 2
- Imatinib Mesylate in Patients With Various Types of Malignancies Involving Activated Tyrosine Kinase EnzymesCompletedNCT00171912Phase 2
- Study Comparing Standard Dose and High-dose Imatinib Mesylate in Patients With Chronic Phase Philadelphia Chromosome Positive (Ph+) Chronic Myelogenous Leukemia (CML)CompletedNCT00171899Phase 4
- Octreotide Efficacy and Safety in First-line Acromegalic PatientsCompletedNCT00171886Phase 4
- A Study to Determine the Safety and Efficacy of Imatinib Mesylate in Patients With Idiopathic Hypereosinophilic SyndromeTerminatedNCT00171860Phase 2
- Study of the Efficacy and Safety of Letrozole Combined With Trastuzumab in Patients With Metastatic Breast CancerTerminatedNCT00171847Phase 4
- A Study Assessing the Efficacy and Safety of Deferasirox in Patients With Transfusion-dependent Iron OverloadCompletedNCT00171821Phase 3
- Letrozole in the Treatment of Advanced or Recurrent Hormone Receptor Positive Endometrial CancerCompletedNCT00171808Phase 2
- Efficacy and Safety of Rivastigmine in Patients With Traumatic Brain Injury and Cognitive ImpairmentCompletedNCT00171795Phase 3
- Hypertension and Cardiovascular Risk FactorsCompletedNCT00171782Phase 4
- Atrial Fibrillation Feasibility Certoparin Trial - AFFECTCompletedNCT00171769Phase 3
- Study to Compare the Effect of Valsartan vs Atenolol on Pro-thrombotic State in Hypertensive Patients.CompletedNCT00171756Phase 4
- Efficacy and Safety of Cyclosporine Microemulsion in Diabetic Adult Stable Liver Transplant RecipientsCompletedNCT00171743Phase 4
- Conversion From Tacrolimus to Cyclosporine Microemulsion in Liver Transplant Patients With New Onset Diabetes After the 3rd Month Post-transplantCompletedNCT00171717Phase 4
- Safety of Diclofenac Sodium Gel in Knee OsteoarthritisCompletedNCT00171691Phase 3
- Efficacy and Safety of Diclofenac Sodium Gel in Knee OsteoarthritisCompletedNCT00171678Phase 3
- Efficacy and Safety of Diclofenac Sodium Gel in Hand OsteoarthritisCompletedNCT00171665Phase 3
- Efficacy and Safety of Diclofenac Sodium Gel in Hand OsteoarthritisCompletedNCT00171652Phase 3
- The Use of Zoledronic Acid in Men on Androgen Deprivation Therapy for Prostate Cancer With Preexisting OsteoporosisCompletedNCT00171639Phase 3
- Efficacy and Safety of Diclofenac Sodium Gel in Knee OsteoarthritisCompletedNCT00171626Phase 3
- A Study of Octreotide Depot vs Saline Control in Pediatric Hypothalamic Obesity PatientsCompletedNCT00171613Phase 4
- Antialbuminuric Effects of Valsartan and LisinoprilTerminatedNCT00171600Phase 4
- Study of the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Effects of Vatalanib in Combination With Capecitabine in Patients With Advanced CancerCompletedNCT00171587Phase 1/2
- Antiproteinuric Effect of Valsartan and LisinoprilCompletedNCT00171574Phase 4
- Valsartan/Hydrochlorothiazide Combination vs Amlodipine in Patients With Hypertension, Diabetes, and Albuminuria.CompletedNCT00171561Phase 4
- Cardiovascular Risk Evaluation in Clinical Practice in Metabolic Syndrome PatientsCompletedNCT00171548
- Efficacy and Safety of Valsartan/Amlodipine Combination in Patients With Severe HypertensionCompletedNCT00171535Phase 3
- Preference of Tegaserod vs. PEG 3350 in Patients With ConstipationCompletedNCT00171522Phase 4
- Efficacy and Safety of Cyclosporine Microemulsion Given Once a Day in Adult Stable Liver Transplant RecipientsCompletedNCT00171509Phase 4
- Evaluation of Cyclosporine Microemulsion and Tacrolimus on the Rate of New Onset Diabetes Mellitus in Kidney Transplantation RecipientsCompletedNCT00171496Phase 4
- Assessment of the Role of Tegaserod Therapy in the Management of Gastroesophageal Reflux Disease (GERD) Symptoms in Patients With Incomplete Response to Proton Pump Inhibitors (PPIs).CompletedNCT00171483Phase 3
- The Role of Tegaserod Therapy in the Management of Dyspeptic Symptoms in Female Patients on Proton Pump Inhibitors for the Treatment of Heartburn.CompletedNCT00171470Phase 3
- The Effects of Tegaserod on Mechanical Sensitivity of the Esophagus and Stomach in Patients With Heartburn and Dyspepsia.CompletedNCT00171457Phase 3
- Comparison of Two Treatment Strategies in Hypertensive PatientsCompletedNCT00171444Phase 4
- The Effect of Tegaserod on Patterns of Flow in the Small Bowel of Patients With Irritable Bowel Syndrome (IBS)TerminatedNCT00171431Phase 3
- Assessment of the Effects of Tegaserod in the Management of Gastroesophageal Reflux Disease (GERD) in Patients With Incomplete Response to Proton Pump Inhibitors (PPIs).CompletedNCT00171418Phase 3
- A Clinical Study to Evaluate the Long-term Safety (12 Months) of the Combination of Aliskiren 300 mg and Hydrochlorothiazide 25 mgCompletedNCT00171405Phase 3
- Clinical Study to Evaluate the Tolerability, Safety and Efficacy of Enteric-coated Mycophenolate Sodium, After Equimolar Conversion From Mycophenolate Mofetil (MMF), in Patients With Stable Renal Transplant Receiving TacrolimusCompletedNCT00171392Phase 3
- Clinical Study to Evaluate the Tolerability, Safety and Efficacy of Enteric-coated Mycophenolate Sodium After Equimolar Conversion From Mycophenolate Mofetil (MMF) in Patients With Renal TransplantCompletedNCT00171379Phase 3
- A Study Comparing the Response of Patients With Hypertension to Amlodipine or Amlodipine Plus Benazepril.CompletedNCT00171366Phase 3
- A Study to Describe Vascular and Renal Effects and Safety of Valsartan in Patients With High Blood PressureCompletedNCT00171353Phase 4
- Efficacy and Safety of Fluvastatin or Valsartan and Their Combination in Dyslipidemic Patients With Hypertension and Endothelial DysfunctionCompletedNCT00171327Phase 4
- Efficacy and Safety Study of Fluvastatin and Ezetimibe Combined Versus Fluvastatin AloneCompletedNCT00171288Phase 3
- Fluvastatin in the Therapy of Acute Coronary SyndromeCompletedNCT00171275Phase 4
- Trial to Evaluate the Efficacy of Fluvastatin on Certain MarkersCompletedNCT00171262Phase 4
- Efficacy and Safety of Fluvastatin in Children With Heterozygous Familial HypercholesterolemiaCompletedNCT00171236Phase 3
- Efficacy, Safety, and Tolerability of Darifenacin in Patients Aged > 65 Years With Overactive BladderCompletedNCT00171184Phase 4
- A Study of Long-term Treatment With Deferasirox in Patients With Beta-thalassemia and Transfusional HemosiderosisCompletedNCT00171171Phase 3
- A 12-Week Study to Evaluate the Efficacy of Darifenacin to Increase the Warning Time in Patients With Overactive Bladder.CompletedNCT00171145Phase 3
- VALENCE: Valsartan Versus Atenolol on Exercise Capacity in Hypertensive Overweight Postmenopausal WomenCompletedNCT00171132Phase 4
- A Study in Patients With Diabetes Mellitus Type II of the Effect on Albuminuria of 24 Week Treatment With Valsartan, Benazepril, and Valsartan+BenazeprilTerminatedNCT00171119Phase 4
- Efficacy and Safety of Valsartan Versus Placebo on Exercise Tolerance in Patients With Heart FailureCompletedNCT00171106Phase 4
- A 10-12 Week Study to Evaluate the Safety and Efficacy of 320 mg Valsartan and 80 mg Simvastatin in Combination and as Monotherapies in Treating Hypertension and HypercholesterolemiaCompletedNCT00171093Phase 3
- VALID: Study to Compare the Reduction of Predialysis Systolic Blood Pressure With Valsartan Compared to Irbesartan in Patients With Mild to Moderate Hypertension on Long-term HemodialysisCompletedNCT00171080Phase 3
- VALERIA: Valsartan in Combination With Lisinopril in Hypertensive Patients With MicroalbuminuriaCompletedNCT00171067Phase 3
- A Study Of Valsartan Used To Treat Hypertension For Up To 13 Months In Hypertensive Children Ages 6 - 16 Years Of AgeCompletedNCT00171041Phase 3
- A Study Of Valsartan Used To Treat Hypertension For Up To 56 Weeks In Children Ages 1 - 5 Years Who Have HypertensionCompletedNCT00171028Phase 3
- VALORY Study of Valsartan/Hydrochlorizide for Patients Who do Not Respond Adequately to Olmesartan MedoxomilCompletedNCT00171015Phase 3
- Efficacy and Safety of Valsartan/Amlodipine Combination in Hypertensive Patients Not Controlled With Amlodipine AloneCompletedNCT00171002Phase 3
- Valsartan/Hydrochlorothiazide Combination in Hypertensive Patients Not Controlled With Valsartan AloneCompletedNCT00170989Phase 3
- A Year Long Study to Evaluate the Safety of the Combination of Valsartan (320 mg) and Amlodipine (5 mg) in Patients With HypertensionCompletedNCT00170976Phase 3
- Efficacy and Safety of Valsartan/Amlodipine Combination in Hypertensive Patients Not Controlled With Valsartan AloneCompletedNCT00170963Phase 3
- A 16 Week Study to Evaluate the Effect on Insulin Sensitivity of Valsartan (320 mg) and Hydrochlorothiazide (25 mg) Combined and Alone, in Patients With Metabolic SyndromeCompletedNCT00170937Phase 4
- To Find Out Whether Valsartan With or Without Other Blood Pressure Medications Would Improve the Ability of the Heart to Fill and Empty, and the Ability of the Heart Muscle to Relax Adequately in People With High Blood Pressure.CompletedNCT00170924Phase 4
- Efficacy and Safety of AAE581 in Postmenopausal Women With Osteopenia/Osteoporosis.CompletedNCT00170911Phase 2
- Safety and Efficacy of Lumiracoxib Versus Naproxen in Acute Musculoskeletal PainCompletedNCT00170898Phase 4
- Everolimus in Combination With Cyclosporine Microemulsion in de Novo Renal Transplant RecipientsCompletedNCT00170885Phase 4
- 6 Week Open-label Trial With Lumiracoxib 200mg o.d. in Primary Knee Osteoarthritis or Rheumatoid ArthritisCompletedNCT00170872Phase 3
- Everolimus Versus Mycophenolate Mofetil in Combination With Reduced Dose Cyclosporine Microemulsion in Maintenance Heart Transplant RecipientsCompletedNCT00170859Phase 4
- Safety, Tolerability and Efficacy of Everolimus With Lower Versus Higher Levels of Tacrolimus in de Novo Renal Transplant PatientsCompletedNCT00170833Phase 3
- Efficacy and Safety of the Switch From Sirolimus to Everolimus in Stable Maintenance Renal Transplant Patients Receiving a Calcineurin Inhibitor Free RegimenCompletedNCT00170820Phase 4
- Renal Safety of Everolimus in Addition to Cyclosporine Microemulsion in Cardiac Transplant Recipients.CompletedNCT00170794Phase 3
- Efficacy and Safety of Lumiracoxib 400 mg Once Daily in Acute Flares of GoutCompletedNCT00170781Phase 4
- Cognitive Effects of Darifenacin and Oxybutynin Extended Release in Volunteers Aged 60 and OverCompletedNCT00170768Phase 2
- A Long-Term Safety, Tolerability and Efficacy Study of Darifenacin in Adult Patients With Overactive BladderCompletedNCT00170755Phase 3
- Study to Assess the Efficacy and Safety of Monthly Octreotide Intramuscular Injections in Patients With Proliferative Diabetic Retinopathy After Lasercoagulation This Study is Not Being Conducted in the United States.TerminatedNCT00170742Phase 3
- A Study to Compare Ocular Safety and Tolerability of Eye Drops Containing Prednisolone Acetate in Patients With Intraocular Inflammation After Cataract SurgeryCompletedNCT00170729Phase 4
- Effects of Octreotide Acetate on Circulating Levels of Chromogranin A in Advanced Prostate Cancer PatientsCompletedNCT00166725Phase 2
- Phase II Study of Imatinib Mesylate in Patients With Life Threatening Malignant Rare DiseasesCompletedNCT00154388Phase 2
- The Efficacy and Safety of Oral Oxcarbazepine 300-1200 mg/Day as Adjuvant Therapy in the Treatment of Adolescents With Impulsivity and Aggressive Behavior in Conduct Disorder This Study is Not Being Conducted in the United States.CompletedNCT00154362Phase 4
- Efficacy Study of Imatinib Mesylate to Treat Philadelphia-Positive Acute Lymphocytic LeukemiaCompletedNCT00154349Phase 2
- A Study of Imatinib 400 mg Once Daily in Combination With Methotrexate in the Treatment of Rheumatoid Arthritis.CompletedNCT00154336Phase 2
- The Efficacy and Safety of Oral Oxcarbazepine 300-1200 mg/Day as Adjuvant Therapy in the Treatment of Bipolar Disorder I or II This Study is Not Being Conducted in the United States.CompletedNCT00154323Phase 4
- Effects of Blood Pressure Reduction on High Sensitivity C-Reactive Protein (hsCRP)CompletedNCT00154271Phase 4